REGD. NO. D. L.-33004/99
The Gazette of India
EXTRAORDINARY
PART I—Section 1
PUBLISHED BY AUTHORITY
No. 305] NEW DELHI, TUESDAY, NOVEMBER 13, 2001/KARTIKA 22,1923
3523 GI/2001
(1)2 ^ THE GAZETTE OF INDIA; EXTRAORDINARY [PART I—SEC. 1] 3
MINISTRY OF COMMERCE AND INDUSTRY
(Department of Commerce)
PUBLIC NOTICE
New Delhi, Ihe 13th November, 2001
NO. 50 (RE-01)/1997—2002
F. No. 01/94/180/051/AM 02/PCIV.—In exercise of powers conferred under Paragaph 4.11 of the Export and Import Policy 1997—2002, as notifed in the Gazette of India Extraordinary, Part-II Section 3, Sub-section (ii) vide S. O. No. 283 (E) dated 31-3-1997, the Director General of Foreign Trade hereby makes the following amendment in Handbook (Vol. I), (RE-01), 1997—2002.
1) The following amendments shall be made in Appendix 28 A which pertains to the DEPB rate list
(i) Product Group - Chemicals (Product Code No 62)
(a) The following entries are amended as under with effect from 02.11.2001;
4 THE GAZETTE OF INDIA: EXTRAORDINARY [PART 1—SEC. 11| S.No 37 | Export Product Formulations (a) Injections (b) Syrup/ Oral Suspension (c) Tablets/ Capsules (d) Intravenous infusion of bulk drugs for which no specific DEPB rates have been notified Note: This rate is applicable only for those formulations i.e. injections/ syrups/ oral suspensions/ tablets/ capsules for which no specific DEPB rates have been notified. For the above formulations of two or more bulk drugs, the DEPB rate admissible will be as per Policy Circular No. 20 (RE-00)/2000- 2001, dated 31.07,2001 | DEPB Rate (a)60% of the DEPB rate for the relevant bulk drag except in the case of formulations covered under S.No 37A (b) 60% of the DEPB rate for the relevant bulk drug except in the case of formulations covered under S.No 37A (c) 70% of the DEPB rate for the relevant bulk drug except in the case of formulations covered under S.No 37A (d) 65% of the DEPB rate for the relevant bulk drug except in the case of formulations covered under S.No 37A | Value Cap for DEPB entitlement |
| 40 | Formulation of Bulk Drug not covered at S.No 37, 37A, 38 and 39 (a) Injections (b) Syrup/ Oral Suspension (c) Tablets/ Capsules (d) Intravenous infusion | (a) 8.00 (b) 8.00 (c) 12.00 (d) 10.00 |
2) A number of DEPB licences have expired in respect of export of formulations relating to the Product Group - Chemicals and yarn dyed Made ups relating to the Product Group- Textiles, due to differences in interpretation , It has therefore been decided that DEPB relating to S.No 37 and 40 of the Product Group - Chemical (Product Code 62) and S.No 69 and 72 of Product Group - Textiles (Product Code 89) shall be revalidated for a period of 6 months from the date of such endorsement by the licencing authority against submission of a request and TR/ demand draft for Rs 200. However no revalidation shall be granted by the licensing authority in cases where misrepresentation/ fraud has come to the notice of the licensing authority or adjudicating orders have already been passed. This issues in public interest
N. L. LAKHANPAL, Director General of Foreign Trade Printed by the Manager. Govt. of India Press, Ring Road, Mayapuri, Now Delhi-110064 and Published by the Controller of Publication!), Delhi-110054.